{"id":205839,"date":"2018-04-12T12:35:02","date_gmt":"2018-04-12T12:35:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=205839"},"modified":"2018-04-12T12:35:02","modified_gmt":"2018-04-12T12:35:02","slug":"pharmacogenomics-market-2018-statistics-by-technology-microarray-sequencing-polymerase-chain-reaction-ravishing-growth-of-58-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharmacogenomics-market-2018-statistics-by-technology-microarray-sequencing-polymerase-chain-reaction-ravishing-growth-of-58-by-2023_205839.html","title":{"rendered":"Pharmacogenomics Market 2018 Statistics | By Technology &#8211; Microarray, Sequencing, Polymerase Chain Reaction | Ravishing Growth of 5.8% by 2023"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/04\/1523536917.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/04\/1523536917.jpeg\" alt=\"\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Pharmacogenomics Market&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Pharmacogenomics Market Research Report, By Application (Cardiology, Neurological Disorders) By End Users (Hospitals, Research Organizations, Academic Institute) &#8211; Global Forecast till 2023 <\/div>\n<p style=\"text-align: justify;\"><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">The Global <\/span><\/span><\/em><a rel=\"nofollow\" href=\"mailto:https:\/\/www.marketresearchfuture.com\/reports\/pharmacogenomics-market-1177\" data-cke-saved-href=\"mailto:https:\/\/www.marketresearchfuture.com\/reports\/pharmacogenomics-market-1177\"><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Pharmacogenomics Market<\/span><\/span><\/em><\/a><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\"> is expected to grow at a ~CAGR of 5.8% during the forecast period.<\/span><\/span><\/em><\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Competitive Analysis<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">The key players profiled in pharmacogenomics market report includes Myriad <\/span><\/span><\/p>\n<ul>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Genetics Inc. (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">23andMe Inc. (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Pathway Genomics (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">GeneTech (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">GeneDx (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Future Science Group (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Teva Pharmaceutical Industries Ltd. (Israel), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Assurex Health Inc. (U.S.), <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">OneOme (U.S.)<\/span><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Market Overview:<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Pharmacogenomics characterizes how qualities can influence a man&#8217;s reaction to drugs. It is moderately another field and joins pharmacology and genomics. The point of pharmacogenomics is to create compelling and safe medicines. Additionally by pharmacogenomics, drugs measurements can be custom-made to a man&#8217;s hereditary cosmetics. The field of pharmacogenomics is anticipated to treat an extensive variety of medical issues including cardiovascular infections, Alzheimer illness, growth, HIV\/AIDS, and asthma, in not so distant future. <\/span><\/span><\/p>\n<p><strong><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Get a Sample Copy of This Report @ <\/span><\/span><\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/1177\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/1177\"><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">https:\/\/www.marketresearchfuture.com\/sample_request\/1177<\/span><\/span><\/em><\/a><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\"> .<\/span><\/span><\/em><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">As per the Organization for Economic Co-activity and Development (2017), biotech R&amp;D in the business venture division was 11.3%, and 9.4% for U.S. furthermore, France separately in 2014. Besides, in 2016, as indicated by the organization BIOCOM AG, the aggregate turnover for the Germany based biotech organizations was USD 3.7 billion. The above information reasons that the biotechnology business is extending. This developing biotech segment alongside the rising human services uses, and expanding enthusiasm for modified medications will drive the market development. In any case, absence of mindfulness and absence of consistency in pharmacogenomics items will control the market development amid the conjecture time frame.<\/span><\/span><\/p>\n<p><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Regional Analysis:<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">The Americas dominate the global pharmacogenomics market owing to a well-developed healthcare sector and presence of developed economies like the U.S. and Canada. Moreover, increasing number of patients suffering from cardiovascular diseases and rising healthcare expenditure have boosted the growth of the market in America. In 2016, according to the Centres for Diseases Control and Prevention in the U.S., heart disease was the leading cause of death for both men and women. Moreover, it was also estimated that the healthcare expenditure for heart diseases in the U.S. reaches USD 200 billion each year. <\/span><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Europe is the second largest pharmacogenomics market, followed by Asia Pacific. Availability of funds for research and development along with government support and presence of huge patient population within the region will drive the market growth during the forecast period. Moreover, the presence of the developed economies like Germany and France within the region fuels the market growth. <\/span><\/span><\/p>\n<p><strong><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Get Attractive Discount on This Report @ <\/span><\/span><\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/check-discount\/1177\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/check-discount\/1177\"><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">https:\/\/www.marketresearchfuture.com\/check-discount\/1177<\/span><\/span><\/em><\/a><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\"> .<\/span><\/span><\/em><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China and presence of huge opportunities in the market drives the market. According to the Indian Brand Equity Foundation in 2016, the Indian biotech industry is estimated to reach USD 100 billion by 2025 from USD 7 billion in 2015 with a CAGR of 30.46%. <\/span><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">On the other hand, the Middle East &amp; Africa has the least share in the global pharmacogenomics market due to presence of poor economy, low per capita healthcare expenditure and stringent government policies especially in the Africa region. The majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. Moreover, developed economies like Dubai, Saudi Arabia, Dubai, besides others fuels the market growth within the Middle East &amp; Africa region. <\/span><\/span><\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Intended Audience:<\/span><\/span><\/strong><\/p>\n<ul>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Pharmaceutical companies<\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Biotechnological institutes<\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Government and Private Laboratories<\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Research and Development (R&amp;D) Companies<\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Medical Research Laboratories <\/span><\/span><\/li>\n<li style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Market Research and Consulting Service Providers <\/span><\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">&hellip;.Continued<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Inquire about This Report @ <\/span><\/span><\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/enquiry\/1177\" data-cke-saved-href=\"https:\/\/www.marketresearchfuture.com\/enquiry\/1177\"><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">https:\/\/www.marketresearchfuture.com\/enquiry\/1177<\/span><\/span><\/em><\/a><em><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\"> .<\/span><\/span><\/em><\/p>\n<p style=\"text-align: justify;\"><strong><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">About US:<\/span><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-size: 10.0pt;\"><span style=\"font-family: 'Verdana',sans-serif;\">Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &amp; Consulting Services.<\/span><\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Market Research Future<br \/><strong>Contact Person:<\/strong> Akash Anand<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=pharmacogenomics-market-2018-statistics-by-technology-microarray-sequencing-polymerase-chain-reaction-ravishing-growth-of-58-by-2023&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9312<br \/><strong>Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune &#8211;   <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketresearchfuture.com\/enquiry\/1177\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketresearchfuture.com\/enquiry\/1177<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketresearchfuture.com\/enquiry\/1177\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=pharmacogenomics-market-2018-statistics-by-technology-microarray-sequencing-polymerase-chain-reaction-ravishing-growth-of-58-by-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Pharmacogenomics Market&#8221; Pharmacogenomics Market Research Report, By Application (Cardiology, Neurological Disorders) By End Users (Hospitals, Research Organizations, Academic Institute) &#8211; Global Forecast till 2023 The Global Pharmacogenomics Market is expected to grow at a ~CAGR of 5.8% during the forecast &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/pharmacogenomics-market-2018-statistics-by-technology-microarray-sequencing-polymerase-chain-reaction-ravishing-growth-of-58-by-2023_205839.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-205839","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/205839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=205839"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/205839\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=205839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=205839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=205839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}